Showing 2,281 - 2,300 results of 16,418 for search '"Therapy"', query time: 0.11s Refine Results
  1. 2281

    Contrast-Enhanced CT May Be a Diagnostic Alternative for Gastroesophageal Varices in Cirrhosis with and without Previous Endoscopic Variceal Therapy by Qianqian Li, Ran Wang, Xiaozhong Guo, Hongyu Li, Xiaodong Shao, Kexin Zheng, Xiaolong Qi, Yingying Li, Xingshun Qi

    Published 2019-01-01
    “…Additionally, contrast-enhanced CT may be considered for diagnosis of GVNTs in primary prophylaxis population without previous endoscopic variceal therapy and secondary prophylaxis population.…”
    Get full text
    Article
  2. 2282
  3. 2283

    LCZ696 Therapy Reduces Ventricular Tachyarrhythmia Inducibility in a Myocardial Infarction-Induced Heart Failure Rat Model by Po-Cheng Chang, Shien-Fong Lin, Yen Chu, Hung-Ta Wo, Hui-Ling Lee, Yu-Chang Huang, Ming-Shien Wen, Chung-Chuan Chou

    Published 2019-01-01
    “…LCZ696 (valsartan/sacubitril) therapy significantly reduced mortality in patients with heart failure (HF). …”
    Get full text
    Article
  4. 2284
  5. 2285

    Catgutpuncture and ozone therapy combined treatment in vulgar psoriasis. Lucia Íñiguez Landín Clinical Surgical Hospital. 2019- 2021 by Lisbet López Mulet, Yaima Quintana Rojas, Annarelis Pérez Pupo

    Published 2023-05-01
    “…<br /><strong>Objective:</strong> to determine the effectiveness of the combined catgutpuncture-ozone therapy treatment in patients with psoriasis vulgaris.…”
    Get full text
    Article
  6. 2286
  7. 2287

    The effect of the relative dose intensity of chemoradiotherapy on the effectiveness of therapy of locally advanced unresectable non-small cell lung cancer by A. E. Glukhareva, G. V. Afonin, I. V. Kolobaev, L. Yu. Grivtsova, S. A. Ivanov, A.  D.  Kaprin

    Published 2024-03-01
    “…To estimate the number of patients with the preservation of relative dose intensity (RDI) ≥ 80 % of first-line antitumor therapy in patients with unresectable non-small cell lung cancer (NSCLC), and to compare the effectiveness of therapy in groups with optimal and lower RDI.Patients and methods. …”
    Get full text
    Article
  8. 2288
  9. 2289
  10. 2290
  11. 2291
  12. 2292

    Primary Injuries and Secondary Organ Failures in Trauma Patients with Acute Kidney Injury Treated with Continuous Renal Replacement Therapy by Sigrid Beitland, Ingrid Os, Kjetil Sunde

    Published 2014-01-01
    “…Acute kidney injury (AKI) treated with continuous renal replacement therapy (CRRT) is a severe complication in trauma patients. …”
    Get full text
    Article
  13. 2293
  14. 2294

    Subthalamic hGAD65 Gene Therapy and Striatum TH Gene Transfer in a Parkinson’s Disease Rat Model by Deyu Zheng, Xiaohua Jiang, Junpeng Zhao, Deyi Duan, Huanying Zhao, Qunyuan Xu

    Published 2013-01-01
    “…The aim of the present study is to detect a combination method to utilize gene therapy for the treatment of Parkinson’s disease (PD). …”
    Get full text
    Article
  15. 2295
  16. 2296
  17. 2297

    E-Selectin/AAV Gene Therapy Promotes Myogenesis and Skeletal Muscle Recovery in a Mouse Hindlimb Ischemia Model by Antoine J. Ribieras, Yulexi Y. Ortiz, Yan Li, Nga T. Le, Carlos T. Huerta, Francesca A. Voza, Hongwei Shao, Roberto I. Vazquez-Padron, Zhao-Jun Liu, Omaida C. Velazquez

    Published 2023-01-01
    “…These results suggest a potential role for E-sel/AAV gene therapy as a nonsurgical adjunct in patients with life-limiting PAD.…”
    Get full text
    Article
  18. 2298
  19. 2299

    CYP2C19 Genotype‐Guided Antiplatelet Therapy and Clinical Outcomes in Patients Undergoing a Neurointerventional Procedure by Kayla R. Tunehag, Ashton F. Pearce, Layna P. Fox, George A. Stouffer, Sten Solander, Craig R. Lee

    Published 2025-01-01
    “…ABSTRACT In neurovascular settings, including treatment and prevention of ischemic stroke and prevention of thromboembolic complications after percutaneous neurointerventional procedures, dual antiplatelet therapy with a P2Y12 inhibitor and aspirin is the standard of care. …”
    Get full text
    Article
  20. 2300